Rite Aid Corp (RAD)
$0.65
0.00 (0.00%)
RAD Stock Quote Delayed 30 Minutes
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
36.76M
PE Ratio
-0.04
EPS
-17.25
Volume (Avg. Vol.)
Day's Range
-
52-Week Range
$0.38 - $3.16
Dividend & Yield
N/A (N/A)
RAD Stock Predictions, Articles, and Rite Aid Corp News
Rite Aid Stock Is Still One of the Top Stocks to Avoid in 2020
With a heavy debt load and mounting competition, Rite Aid stock is looking like one to avoid as we begin 2020.
4 Top Stock Trades for Friday: TSLA, RAD, GIS, MED
General Mills, Tesla, Rite Aid and Medifast were our top stock trades from Thursday. Let's look at the charts going into Friday.
Rite Aid Earnings: RAD Stock Rockets 43% Higher on Better-Than-Expected Q3
Rite Aid (RAD) earnings for the U.S. pharmacy company's third quarter of fiscal 2020 have RAD stock flying high on Thursday.
3 Big Stock Charts for Wednesday: Alphabet, AT&T, and Rite Aid
Wednesday's 3 big stock charts highlight recent market winners whose rallies may be petering out.
Even With New CEO, Debt-Laden Rite Aid Stock is Best Avoided for Near Term
RAD stock hasn't benefited when management gave up selling electronic cigarettes while taking on CBD products. That's not the turnaround strategy it needs.
The Comfort Zone Is Holding Rite Aid Stock Back
Believe it or not, Rite Aid has the opportunity to maximize its revenue profile. But getting there is a herculean task, leaving Rite Aid stock an avenue best left for speculators.
The Roller Coaster Ride of Rite Aid Stock Is Much Ado About Nothing
RAD stock both rallied by 50% and dropped by 30% in September - and none of it had anything to do with the fundamentals of Rite Aid stock, which remain bad.
There’s No Management Turnaround That Will Boost Rite Aid Stock
Rite Aid stock – don’t wait for any management-led turnaround. This pharmacy retailer is laden with debt, cash flow losses and no clear turnaround plan.
Are Health Plans the Key to Rite Aid’s Savior?
Rather than trying desperately to find a buyer, Rite Aid will leverage their core strengths to bring value-add to their business. This is probably the best play available for Rite Aid stock.
With Any Turnaround Already Priced In, Avoid Rite Aid Stock
With this in mind, the stock is a hard pass. Investors likely can find more solid turnaround plays elsewhere. Given the volatility in the RAD stock prices, shares could shoot higher on speculation. But long term, Rite Aid stock is not a strong investment opportunity.
The Q2 Earnings Bump Is Not a Signal to Buy Rite Aid Stock
Rite Aid (NYSE:RAD) jumped more than 20% last week after exceeding second-quarter earnings guidance. The boost came at a good time. Rite Aid stock has…
Rite Aid Earnings: RAD Stock Soars 5% on Q2 Beat
Rite Aid (RAD) earnings for the second quarter of fiscal 2020 have RAD stock taking off on Thursday on a strong EPS beat.
For Q2 Earnings, Rite Aid Stock Must Bank on Positive Guidance
With Rite Aid reporting Q2 earnings on Thursday, all eyes will focus on the pharmacy retailer’s forward guidance. Unfortunately, that might not be a good thing for RAD stock.
